Hematological Cancer

Hematological malignancies are extremely diverse, and treatment can range from very mild to extremely intense depending on the type of malignancy. Thus, during treatment, some patients may enjoy nearly unchanged daily life and work, while others may require long-term hospitalization and a temporary leave from work. The treatment strategy would be decided depending on factors such as the type of hematological malignancy, disease stage, and patient status, and the patient would be requested to have different lifestyles and working formats depending on the treatment strategy. Treatment modalities for hematologic malignancies include observation, surgery, radiotherapy, chemotherapy, autologous and allogeneic stem cell transplantation, and chimeric antigen receptor T (CAR-T) cell therapy, and we describe how these modalities are incorporated into the treatment of individual hematological malignancies along with a discussion of how work is affected and what kind of precautions are to be taken by the patient. Hematological malignancies discussed here include diffuse large B-cell lymphoma, follicular lymphoma, classic Hodgkin’s lymphoma, multiple myeloma, acute myeloid leukemia, acute lymphoblastic leukemia, and chronic myeloid leukemia. Although obstacles and restrictions accommodate, working while being treated can be possible for many hematological malignancies if treatment-related adverse events are mild and certain safety measures are taken.